ApoE genotype and Alzheimer's disease in adults with down syndrome: Meta-analysis

American Journal on Mental Retardation

Volumn 102, Issue 2, 1997, Pages 103-110

  Prasher, V P ^a   Chowdhury, T A ^a   Rowe, B R ^a   Bain, S C ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; DNA POLYMORPHISM; DOWN SYNDROME; FEMALE; GENOTYPE; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; ONSET AGE;

ADULT; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; DOWN SYNDROME; FEMALE; GENOTYPE; HUMANS; LONGEVITY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0030821988     PISSN: 08958017     EISSN: None     Source Type: Journal    
DOI: 10.1352/0895-8017(1997)102<0103:AGAADI>2.0.CO;2     Document Type: Article

References (33)

1. Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J. Schmachel, D. E., Gaskall, P. C., Rimmlas, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Small, G. W., Roses, A. D., Laines, & J. L. Pericak-Vance, M. A. (1994). Protective effect of apolipoprotein E type 2 for late onset Alzheimer disease. Nature Genetics, 7, 180-184.
2. Crook, R., Hardy, J., & Duff, K. (1994). Single day apolipoprotein E genotyping. Journal of Neuroscience Methods, 53, 125-127.
3. Evenhuis, H. M. (1992). Evaluation of a screening instrument for dementia in ageing mentally retarded persons. Journal of Intellectual Disability Research, 36, 337-347.
4. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
5. Friedman, G., Gabizon, R., Shapira, A., Castel, H., Wertman, E., Matsa, D., Rosenmam, H., Schurr, D., Wirtheim, E., Friedlander, Y., & Ben Yehuda, A. (1995). Association of apolipoprotein E ε4 alleles with Alzheimer's disease but not with Down's syndrome or Creutzfeldt-Jakob disease. Alzheimer's Research, 1, 45-48.
6. Hardy, J. (1995). Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease. American Journal of Medical Genetics (Neuropsychiatric Genetics), 60, 456-460.
7. Hardy, J., Crook, R., Perry, R., Raghavan, R., & Roberts, G. (1994). Apoe genotype and Down's syndrome. Lancet, 343, 979-910.
8. Hyman, B. T., West, H. L., Rebeck, G. W., Lai, F., & Mann, D. M. (1995). Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype. Archives of Neurology, 52, 373-378.
9. Lambert, J-C., Perez-Tur, J., Dupire, M-J., Delacourte, A., Frigard, B., & Chartier-Harlin, M-C. (1996). Analysis of the APOE alleles impact in Down's syndrome. Neuroscience Letters, 200, 57-60.
10. Levy-Lahad, E., Lahad, A., Wijsman, E. M., Bird, T. D., & Schellenberg, G. D. (1995). Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease. Annals of Neurology, 38, 678-680.
11. Mann, D. M. A. (1988). Alzheimer's disease and Down's syndrome. Histopathology, 13, 125-137.
12. Martins, R. N., Clarnette, R., Fisher, C., Broe, G. A., Brooks, W. S., Montgomery, P., & Gandy, S. E. (1995). ApoE genotypes in Australia: Roles in early and late onset Alzheimer's disease and Down's syndrome. NeuroReport, 6, 1513-1516.
13. National Institute on Aging/Alzheimer's Association Working Group. (1996). Consensus statement: Apolipoprotein E genotyping in Alzheimer's disease. Lancet, 347, 1091-1095.
14. Nihira, K., Foster, R., Shellhaas, M., & Leland, H. (1974). AAMD Adaptive Behavior Scale (1974 rev.). Washington, DC: American Association on Mental Deficiency.
15. Oliver, C., & Holland, A. J. (1986). Down's syndrome and Alzheimer's disease: A review. Psychological Medicine, 16, 307-322.
16. Pickering-Brown, S. M., Mann, D. M. A., Bourke, J. P., Roberts, D. A., Balderson, D., Burns, A., & Byrne, J. (1994). Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other B-amyloid-forming diseases. Lancet, 343, 1155.
17. Prasher, V. P. (1994). Temporal relationship between clinical and neuropathological dementia in people with Down syndrome. British Journal of Clinical and Social Psychiatry, 9, 24-25.
18. Prasher, V. P. (1995). Age-specific prevalence, thyroid dysfunction and depressive symptomatology in adults with Down syndrome and dementia. International Journal of Geriatric Psychiatry, 10, 25-31.
19. Prasher, V. P., & Krishnan, V. H. R. (1993). Age of onset and duration of dementia in people with Down syndrome. A study of 98 reported cases. International Journal of Geriatric Psychiatry, 8, 915-922.
20. Roses, A. D. (1994). Apolipoprotein E affects the rate of Alzheimer disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. Journal of Neuropathology and Experimental Neurology, 53, 429-437.
21. Royston, M. C., Mann, D., Pickering-Brown, S. M., Owen, F., Perry, R., Raghavan, R., Khin-Nu, C., Tyrer, S., Day, K., Crook, R., Hardy, J., & Roberts, G. W. (1994). Apolipoprotein E ε2 allele promotes longevity and protects patients with Down syndrome from dementia. NeuroReport, 5, 2583-2585.
22. Saunders, A. M., Schmader, K., Breitner, J. C. S., Benson, M. D., Brown, W. T., Goldfarb, L., Goldgaber, D., Manwaring, M. G., Szymanski, M. H., McCown, N., Dole, K. C., Schmechel, D. E., Strittmatter, W. J., Perkak-Vance, M. A., & Roses, A. D. (1993). Apolipoprotein E4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet, 342, 710-711.
23. Schupf, N., Kapell, D., Lee, J. E., Zigman, W., Canto, B., Tycko, B., & Mayeux, R. (1996). Onset of dementia is associated with apolipoprotein E ε4. Archives of Neurology, 40, 799-801.
24. Smith, A. D., Johnston, S., Sim, E., Nagy, Z., Jobst, K.A., Hindley, N., & King, E. (1994). Protective effect of apo epsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing (OPTIMA). Lancet, 344(I), 473-474.
25. Sorbi, S., Nacmias, B., Forleo, P., Latorraca, S., Gobbini, I., Bracco, L., Piacentini, S., & Amaducci, L. (1994). ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neuroscience Letters, 177, 100-102.
26. van Duijn, C. M., Clayton, D. G., Chandra, C., Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Mortimer, J. A., Rocca, W. A., Sholat, H., Soininen, H., & Hofman, A. (1994). Interaction between genetic and environmental risk factors for Alzheimer's disease: A reanalysis of case-control studies. EURODEM Risk Factors Research Group. Genetic Epidemiology, 11, 539-551.
27. van Duijn, C. M., de Knijff, P., Cruts, M., Wehnert, A., Havekes, L. M., Hofman, A., & van Broeckhoven, C. (1994). Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genetics, 7, 74-78.
28. van Duijn, C. M., de Knijff, P., Wehnert, A., De Voecht, J., Bronzova, J. B., Havekes, L. M., Hofman, A., & Van Broeckhoven, C. (1995). The apolipoprotein E epsilon2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Annals of Neurology, 37, 605-610.
29. van Gool, W. A., Evenhuis, H. M., & van Duijn, C. M. (1995). A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Annals of Neurology, 38, 225-230.
30. Wisniewski, T., & Frangione, B. (1992). Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neuroscience Letters, 135, 235-238.
31. Wisniewski, T., Morelli, L., Wegiel, J., Levy, E., Wisniewski, H. M., & Frangione, B. (1995). The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome. Annals of Neurology, 37, 136-138.
32. World Health Organization. (1992). The ICD-10 classification of mental and behavioral disorders. Clinical descriptions and diagnostic guidelines. Geneva: Author.
33. World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. Geneva: Author.